Trial ID or NCT#

NCT01217008

Status

NOT RECRUITING

Purpose

The purpose of the study is to evaluate the safety of GRNOPC1 administered at a single time-point between 7 and 14 days post injury, inclusive, to patients with neurologically complete spinal cord injuries (SCI).

Investigator(s)

Gary K. Steinberg, MD, PhD

Contact us to find out if this trial is right for you.

CONTACT

Maria Coburn